Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study

Most patients with asthma can control their symptoms with a basic standard of medical care and with maintenance and rescue medication. However, between 5% and 10% of asthmatics worldwide do not achieve control of their symptoms and have recurrent exacerbations and respiratory difficulties. The objec...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojo-Tolosa, Susana, González-Gutiérrez, María Victoria, Sánchez-Martínez, José Antonio, Jiménez-Gálvez, Gonzalo, Pineda-Lancheros, Laura Elena, Gálvez-Navas, José María, Jiménez-Morales, Alberto, Pérez-Ramírez, Cristina, Morales-García, Concepción
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962091/
https://www.ncbi.nlm.nih.gov/pubmed/36839845
http://dx.doi.org/10.3390/pharmaceutics15020523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962091/
https://www.ncbi.nlm.nih.gov/pubmed/36839845
http://dx.doi.org/10.3390/pharmaceutics15020523

Ejemplares similares